Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1998:12 ( Pt 5):848-53.
doi: 10.1038/eye.1998.216.

Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulation

Affiliations
Clinical Trial

Comparison of short- and long-term effects of betaxolol and timolol on human retinal circulation

A Yoshida et al. Eye (Lond). 1998.

Abstract

Purpose: To determine the short- and long-term effects of betaxolol and timolol on human retinal circulation.

Methods: In a double-masked, randomised, placebo-controlled study we evaluated the effects of both a one-drop application and a twice-daily 2-week application of either topical 0.5% betaxolol hydrochloride or topical 0.5% timolol maleate on the retinal circulation in 12 healthy volunteers. Laser Doppler velocimetry was used to detect changes in the retinal venous blood flow.

Results: In both betaxolol- and timolol-treated eyes, intraocular pressure decreased significantly compared with baseline values after both 90 min and 2 weeks. In betaxolol-treated eyes, retinal blood flow did not change significantly after 90 min, but increased significantly (14 +/- 9%; p = 0.02) compared with baseline after 2 weeks. In timolol-treated eyes, retinal blood flow decreased significantly (18 +/- 5%: p = 0.04) compared with baseline after 90 min, and also decreased significantly (14 +/- 6%; p = 0.04) compared with baseline after 2 weeks.

Conclusions: Retinal blood flow increases as a long-term effect of betaxolol and decreases as both a short- and long-term effects of timolol.

PubMed Disclaimer

LinkOut - more resources